Vivimed Labs Limited enters Corporate Insolvency Resolution Process

IBC 17 Jun 2026 · Announced· ✓ Verified

Vivimed Labs Limited notified the National Stock Exchange (NSE) of the commencement of Corporate Insolvency Resolution Process on 17 June 2026, per the NSE archives filing 'Updates_to_CIRP.pdf'. The CIRP is the statutory insolvency resolution mechanism under the Insolvency and Bankruptcy Code, 2016, typically initiated following an admission order by the National Company Law Tribunal (NCLT). During CIRP, an Insolvency Professional assumes management of the corporate debtor and creditors file claims toward a resolution plan or liquidation outcome within a 180-day statutory window (extendable by 90 days).

Why it mattersCIRP entry by a listed pharma entity triggers mandatory exchange disclosure, trading restrictions pending resolution, and creditor claim procedures under IBC-key gating event for restructuring or liquidation path and stakeholder recovery timeline.
SectorPharma & Healthcare
[object Object][object Object][object Object][object Object][object Object][object Object][object Object][object Object][object Object]

Sources

Open in the live tracker →

Related deals